Cerillion warns of lower first-half revenue, earnings

(Sharecast News) - Cerillion said in an update on Wednesday that first-half revenue and earnings were expected to fall year-on-year, with performance again weighted heavily towards the second half, as the software group pointed to contract timing and a lack of high-margin licence revenue in the period.

The AIM-traded billing, charging and customer relationship management software provider said revenue for the six months ended 31 March was expected to be about £18.0m, down from £20.9m a year earlier, while EBITDA was seen at around £6.2m versus £9.9m.

It said that reflected the timing of contracts and the fact that, as expected, "very little high-margin software licence revenue was recognised in the first half of 2026".

Cerillion said the key development in the half was the signing of Omantel in January as a major new client under a contract worth about £42.5m over its term.

The firm described it as its largest contract win to date and said implementation remained on track, with the deal expected to make a significant contribution in the second half of the financial year.

The expected improvement later in the year was supported by the anticipated unwinding of a strong back-order book.

New orders had doubled to £39.6m as at 30 March, from £19.6m a year earlier, driven mainly by the Omantel contract as well as demand from existing customers.

Cerillion also said its balance sheet remained strong, with net cash at the half-year end of about £32.5m, up from £31.2m a year earlier.

The board said that, based on progress so far, the expected second-half income mix and anticipated new orders from existing customers, the company remained well positioned to meet market expectations for the full year.

Cerillion added that its pipeline of new business opportunities remained strong as it continued to invest in the business to support growth.

The company said it would publish interim results on 1 June.

At 1011 BST, shares in Cerillion were down 5.59% at 1,350p.

Reporting by Josh White for Sharecast.com.

See latest RNS on Investegate

Cerillion